Nurse Practitioner in Tyrone, PA Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Morgan Sage Goldizen, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 522 Oak St, Tyrone, PA 16686 Phone: 814-650-9000 |
 Adam Powers, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 509 W 20th St, Tyrone, PA 16686 Phone: 814-934-2685 Fax: 814-527-3137 |
Dawn Renee Landeck, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 951 Washington Ave, Tyrone, PA 16686 Phone: 814-684-0320 |
Lannette Marie Fetzer, CRNP, FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 4136 Green Gates Ln, Tyrone, PA 16686 Phone: -- |
Ashley Mcmanigal, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 509 W 20th St, Tyrone, PA 16686 Phone: 814-312-3486 |
News Archive
GA²LEN and EAACI warn: Older antihistamines in OTC allergy medications may be hazardous
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
Experts highlight triumph over polio and hope to do the same for COVID-19
For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching money was perilous.
Probiotics could give us safer pork products
Probiotics, the friendly bacteria beloved of yoghurt advertisers, may be an effective substitute for growth promoting antibiotics in pigs, giving us safer pork products, according to scientists speaking (Wednesday 5 September 2007) at the Society for General Microbiology's 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007.
Presentation of results from open-label extension study of Xenazine
Lundbeck Inc. today announced the presentation of results from an open-label extension study of Xenazine- (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Data from this study demonstrated that after an 80-week treatment period, subjects treated with Xenazine experienced a statistically significant reduction in chorea score (p< 0.0001) as measured using the Unified Huntington's Disease Rating Scale (UHDRS) compared with baseline.
ACAAI president available to comment on School Access to Emergency Epinephrine Act
Dr. Stanley Fineman, president of the American College of Allergy, Asthma and Immunology, (ACAAI) is available to comment on the School Access to Emergency Epinephrine Act, a federal bill introduced today that will help make epinephrine available in schools for the immediate treatment of anaphylactic reactions to food or other allergens.
› Verified 1 days ago